Sakhanda Wire
NVDA $154.51 -1.04% MSFT $506.49 -2.22% GOOGL $281.27 -0.86% META $621.51 -0.78% AMZN $256.90 -0.33%
← Back to the news

Google DeepMind releases AlphaGenome 2 for cell-specific variant analysis

Google DeepMind has released AlphaGenome 2, a conditional DNA sequence-to-function model designed to predict regulatory activity and genetic variant effects for particular cell states. It processes a 1 Mb (1,048,576 bp) human or mouse DNA window and one condition per call. The condition is a 256-dimensional embedding that can be derived from raw single-cell RNA sequencing counts, allowing the system to represent previously unseen cell states without fine-tuning.

The model uses a convolutional encoder, an 11-block transformer and a decoder, with conditioning applied through FiLM layers. Its outputs include RNA coverage, CAGE, splicing, chromatin accessibility, histone marks, transcription-factor binding, contact maps and, newly, CpG methylation. Training incorporated bulk data and 3,977 single-cell RNA and ATAC pseudobulk tracks from 36 studies, followed by refinement, distillation and post-training with an expression encoder trained on more than 100 million human scRNA-seq profiles.

In DeepMind’s evaluation, AlphaGenome 2 raised causal-variant recall at 90% precision on TenK10K sc-eQTLs from 16% for fine-tuned AlphaGenome 1 to 30%, while direction-of-effect recall increased from 23% to 43%. It also achieved 0.78 enhancer-gene AUPRC on held-out ENCODE-rE2G CRISPRi data. The model is currently available through a hosted AlphaGenome API for non-commercial research; weights are planned after final publication.

Written by Sakhanda Wire AI from reporting by MarkTechPost. Facts, quotes and full context are in the original article below.

Originally published by MarkTechPost on

Read the original on MarkTechPost ↗

The reporting and the image belong to MarkTechPost and are credited and linked above; the text on this page is Sakhanda Wire's own summary.

← Back to the news

More stories

All the latest news